Solid-state analysis of the active pharmaceutical ingredient in drug products.

[1]  M. Blanco,et al.  Development and validation of a method for the polymorphic analysis of pharmaceutical preparations using near infrared spectroscopy. , 2003, Journal of pharmaceutical sciences.

[2]  S. Byrn,et al.  Solid-state nuclear magnetic resonance spectroscopy--pharmaceutical applications. , 2003, Journal of pharmaceutical sciences.

[3]  Jukka Rantanen,et al.  Effects of excipients on hydrate formation in wet masses containing theophylline. , 2003, Journal of pharmaceutical sciences.

[4]  R. Suryanarayanan,et al.  X-ray powder diffractometric method for quantitation of crystalline drug in microparticulate systems. I. Microspheres. , 2002, Journal of pharmaceutical sciences.

[5]  S. Bates,et al.  Quantifying amorphous content of lactose using parallel beam X-ray powder diffraction and whole pattern fitting. , 2001, Journal of pharmaceutical and biomedical analysis.

[6]  S. Byrn,et al.  Chemical reactivity in solid-state pharmaceuticals: formulation implications. , 2001, Advanced drug delivery reviews.

[7]  K R Morris,et al.  Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes. , 2001, Advanced drug delivery reviews.

[8]  L. S. Taylor,et al.  Evaluation of solid-state forms present in tablets by Raman spectroscopy. , 2000, Journal of pharmaceutical sciences.

[9]  M. J. Clarke,et al.  Physicochemical factors governing the performance of nedocromil sodium as a dry powder aerosol. , 2000, Journal of pharmaceutical sciences.

[10]  S. Chemburkar,et al.  Dealing with the Impact of Ritonavir Polymorphs on the Late Stages of Bulk Drug Process Development , 2000 .

[11]  H. Brittain.  Polymorphism in Pharmaceutical Solids , 1999 .

[12]  R. Suryanarayanan,et al.  Polymorphism in anhydrous theophylline--implications on the dissolution rate of theophylline tablets. , 1997, Journal of pharmaceutical sciences.

[13]  D. Tang-Liu,et al.  Influence of pH and buffer concentration on the ocular bioavailability of ophthalmic AGN 191103 formulations in albino rabbits , 1997 .

[14]  R. Suryanarayanan,et al.  Identification of drugs in pharmaceutical dosage forms by X-ray powder diffractometry. , 1997, Journal of pharmaceutical and biomedical analysis.

[15]  A. Bauer-Brandl.  Polymorphic transitions of cimetidine during manufacture of solid dosage forms , 1996 .

[16]  T. Threlfall.  Analysis of organic polymorphs. A review , 1996 .

[17]  David E. Bugay,et al.  Physical Characterization of Pharmaceutical Solids , 1995, Pharmaceutical Research.

[18]  Stephen Byrn,et al.  Pharmaceutical Solids: A Strategic Approach to Regulatory Considerations , 1995, Pharmaceutical Research.

[19]  Zheng Wang,et al.  Effect of 2-Hydroxypropyl-β-cyclodextrin on Crystallization and Polymorphic Transition of Nifedipine in Solid State , 1994, Pharmaceutical Research.

[20]  Kenneth R. Morris,et al.  Characterization of humidity-dependent changes in crystal properties of a new HMG-CoA reductase inhibitor in support of its dosage form development , 1994 .

[21]  P. Paronen,et al.  Effects of grinding and compression on crystal structure of anhydrous caffeine , 1993 .

[22]  D. Bugay.  Solid-State Nuclear Magnetic Resonance Spectroscopy: Theory and Pharmaceutical Applications , 1993, Pharmaceutical Research.

[23]  S. Byrn,et al.  Solid-State Nuclear Magnetic Resonance (NMR) Spectra of Pharmaceutical Dosage Forms , 1993, Pharmaceutical Research.

[24]  M. Otsuka,et al.  Effects of Tableting Pressure on Hydration Kinetics of Theophylline Anhydrate Tablets , 1991, The Journal of pharmacy and pharmacology.

[25]  N Kaneniwa,et al.  Effects of Temperature and Pressure During Compression on Polymorphic Transformation and Crushing Strength of Chlorpropamide Tablets , 1991, The Journal of pharmacy and pharmacology.

[26]  N Kaneniwa,et al.  Effects of the Mechanical Energy of Multi‐tableting Compression on the Polymorphic Transformations of Chlorpropamide , 1989, The Journal of pharmacy and pharmacology.

[27]  E. Vadas,et al.  Drug-excipient interaction study of enalapril maleate using thermal analysis and scanning electron microscopy , 1987 .

[28]  P. York.  Solid-state properties of powders in the formulation and processing of solid dosage forms , 1983 .

[29]  B. Foster.  Raman microscopy: Taking chemical microscopy to the next level , 2003 .

[30]  Y. Guo,et al.  Physical characteristics and chemical degradation of amorphous quinapril hydrochloride. , 2000, Journal of pharmaceutical sciences.

[31]  H. Brittain,et al.  EFFECTS OF PHARMACEUTICAL PROCESSING ON DRUG POLYMORPHS AND SOLVATES , 1999 .

[32]  K R Morris,et al.  Solid-state NMR and IR for the analysis of pharmaceutical solids: polymorphs of fosinopril sodium. , 1993, Journal of pharmaceutical and biomedical analysis.

[33]  M. Otsuka,et al.  Effects of Environmental Temperature and Compression Energy on Polymorphic Transformation During Tabletting , 1993 .

[34]  H. Ozawa,et al.  Effect of moisture on crystallization of theophylline in tablets , 1992 .

[35]  Deane K. Smith,et al.  Particle Statistics and Whole-Pattern Methods in Quantitative X-Ray Powder Diffraction Analysis , 1991 .

[36]  A. Mateos.  Quantitative XRD Analysis by Partial Least Squares Application in a Commercial Product , 1991 .

[37]  J. Carstensen.  Effect of Moisture on the Stability of Solid Dosage Forms , 1988 .

[38]  J. Guyot,et al.  Polymorphic Transitions of Carbamazepine During Grinding and Compression , 1986 .

[39]  Eric Doelker,et al.  Polymorphic Transformation of Some Drugs Under Compression , 1985 .

[40]  S. Byrn.  Solid state chemistry of drugs , 1982 .